Ray Therapeutics

Recent Finacing

Series B

Recent Raise

$125M

Ray Therapeutics is a clinical-stage biopharmaceutical company advancing optogenetic therapies to restore vision in patients with retinal degenerative diseases.

Founded 2021

California, United States

11-50

Private

raytherapeutics.com